Actelion Pharmaceuticals Ltd

Switzerland


 
Total IP 552
Total IP Rank # 2,378
IP Activity Score 3/5.0    150
IP Activity Rank # 4,573
Parent Entity Actelion Ltd
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

46 35
38 54
259 62
58
 
Last Patent 2024 - Process for manufacturing a diph...
First Patent 1994 - Method of inhibiting glycolipid ...
Last Trademark 2024 - EDVANCI
First Trademark 2000 - ZAVESCA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune...
Invention Pharmaceutical composition comprising a diphenylpyrazine derivative. The present invention relate...
Invention Pharmaceutical composition comprising a diphenylpyrazine derivative. The present invention relat...
Invention Pharmaceutical combination comprising a selective s1p1 receptor agonist. The present invention r...
2023 G/S Pharmaceutical preparations, excluding pharmaceutical preparations in relation to blood circulati...
Invention In vitro dissolution test. The present invention relates to testing samples comprising calcium;{4...
Invention Pyrazolopyrrolopyridazines and their uses as pdgfr inhibitors. The disclosure is directed to comp...
Invention Combination of macitentan and tadalafil for the treatment of pulmonary arterial hypertension. The...
Invention Methods and compositions for detecting or aiding diagnosis of pulmonary hypertension. Biomarkers ...
Invention Injectable pharmaceutical composition comprising a diphenylpyrazine derivative. The present inven...
Invention Triazolopyridine and benzoisoxazole carboxamides and their uses as pdgfr inhibitors. The disclosu...
Invention Pyrrolopyridine carboxamides and their uses as pdgfr inhibitors. The disclosure is directed to co...
Invention Pyrazolothiazole carboxamides and their uses as pdgfr inhibitors. The disclosure is directed to c...
Invention Pyrazolopyrazine carboxamides and their uses as pdgfr inhibitors. The disclosure is directed to c...
Invention Diphenylpyrazine compounds as prodrugs. The present invention relates to a pharmaceutical composi...
Invention Methods of slowing an increase in brain ventricular volume. The disclosure relates to methods of ...
Invention Controlled release compositions. The present disclosure related to a pharmaceutical formulation c...
2022 Invention Dispersible tablet for oral administration. The present invention is directed to pharmaceutical ...
Invention Methods for treating multiple sclerosis. The disclosure relates to methods of preserving myelinat...
Invention Methods and compositions for predictive outcomes for pulmonary arterial hypertension treatment. B...
Invention Methods of treating multiple sclerosis. The disclosure relates to methods of treating multiple sc...
Invention Pharmaceutical composition for the treatment of pulmonary arterial hypertension. The present inv...
Invention Bmp9 variant polypeptides and uses thereof. Isolated BMP9 and pro-BMP9 mutant polypeptides are de...
Invention Pyrazolopyrimidines and their uses as pdgfr inhibitors. The disclosure is directed to compounds ...
Invention Pyrazolopyrimidines and their uses as pdgfr inhibitors. The disclosure is directed to compounds o...
Invention Dispersible tablet for oral administration. The present invention is directed to pharmaceutical c...
Invention Methods of treating pulmonary hypertension. This invention relates to methods of treating pulmona...
Invention Pharmaceutical composition comprising macitentan for the treatment of chronic thromboembolic pulm...
G/S Pharmaceutical preparations; pharmaceuticals preparations for the treatment of cardiovascular and...
Invention Pharmaceutical dosage system. A pharmaceutical dosage system includes a blister pack and a plural...
G/S Educational services, namely, providing podcasts in the field of pulmonary hypertension Providing...
G/S Human pharmaceuticals for treatment of pulmonary arterial hypertension Providing information in t...
Invention Methods for treating pulmonary hypertension in patients with left ventricular assist device impla...
Invention Process for manufacturing a diphenylphrazine derivative. The present invention relates to a proc...
2021 Invention Pyrazolothiazole carboxamides and their uses as pdgfr inhibitors. The disclosure is directed to ...
G/S Educational services Internet platform Medical services; medical information services
G/S Educational services in the field of healthcare; arranging and conducting seminars, workshops, ed...
G/S Providing medical information regarding pharmaceutical products and healthcare to healthcare prof...
Invention Methods of treating and assessing pulmonary arterial hypertension with selexipag. The present di...
Invention Controlled release selexipag composition. The present invention is concerned with controlled rel...
2020 Invention Methods of treating pulmonary arterial hypertension. The disclosure relates to methods of reduci...
Invention Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunc...
Invention Pharmaceutical composition comprising selexipag. The present invention relates to pharmaceutical...
G/S Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceu...
G/S Downloadable software in the nature of an application; Mobile application software; Tablet applic...
Invention Methods for treating pulmonary arterial hypertension. The present disclosure provides methods of...
Invention Methods for treating sarcoidosis-associated pulmonary hypertension. The present disclosure provi...
G/S Mobile application software for training medical practitioners in the detection of signs of pulmo...
G/S Application software, namely, downloadable software for receiving, collecting, displaying, transm...
2019 G/S Application software. Database management; Computer data processing; data file administration. Sa...
G/S Recorded computer application software for receiving, collecting, displaying, transmitting, proce...
G/S Downloadable computer application software for use in real-world evidence generation to facilitat...
G/S Mobile applications; mobile application software. Medical devices. Educational services. Medical ...
G/S Mobile applications; mobile application software; all of the aforementioned goods in the field of...
2018 G/S Printed matter, namely, brochures, booklets, flyers, paper signs, manuals, informational sheets a...
G/S Human pharmaceuticals for treatment of pulmonary arterial hypertension.
G/S Human pharmaceuticals for treatment of pulmonary arterial hypertension
2017 G/S Human pharmaceuticals for the prevention or treatment of auto-immune diseases, pulmonary diseases...
G/S Pharmaceutical preparations.